Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Subacute Sclerosing Panencephalitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Sclerosing Panencephalitis
Journal:
Pediatric neurology
Treatment Used:
Aprepitant
Number of Patients:
62
Published —
July 29, 2020
In this study, researchers evaluated the safety and effectiveness of aprepitant for the treatment of sclerosing panencephalitis.
Condition:
Infection-Associated Opsoclonus in Children in India
Journal:
Journal of child neurology
Treatment Used:
Steroids
Number of Patients:
15
Published —
March 29, 2020
This case series describes children in India who were diagnosed with infection-associated opsoclonus (rapid, uncontrolled eye movement) treated with steroids.
Condition:
Subacute Sclerosing Panencephalitis (SSPE) Causing Rapidly Progressive Dementia and Myoclonic Jerks in a Sexagenarian Woman
Journal:
Tremor and other hyperkinetic movements (New York, N.Y.)
Treatment Used:
Clonazepam and Valproic Acid
Number of Patients:
1
Published —
October 30, 2019
This case report discusses a 62-year-old woman who presented with rapidly progressive dementia and myoclonus who was diagnosed with subacute sclerosing panencephalitis (SSPE) and treated with clonazepam and valproic acid.
Condition:
Subacute Sclerosing Panencephalitis (SSPE)
Journal:
Developmental medicine and child neurology
Treatment Used:
Immunosuppression and Carbemazepine
Number of Patients:
0
Published —
January 26, 2019
This article reported current data relating to the clinical phenotype, epidemiology, and understanding of subacute sclerosing panencephalitis (SSPE), inclusive of preventive interventions.
Showing 1-4 of 4